| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1999;34:253-260.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Docosahexaenoic Acid but Not Eicosapentaenoic Acid Lowers Ambulatory Blood Pressure and Heart Rate in Humans
From the Department of Medicine, University of Western Australia, and the West Australian Heart Research Institute, Perth, Australia.
Abstract—Animal studies
suggest that the 2 major 
3 fatty acids found in fish,
eicosapentaenoic acid (EPA) and docosahexaenoic
acid (DHA), may have differential effects on blood pressure (BP) and
heart rate (HR). The aim of this study was to determine whether there
were significant differences in the effects of purified EPA or DHA on
ambulatory BP and HR in humans. In a double-blind, placebo-controlled
trial of parallel design, 59 overweight, mildly
hyperlipidemic men were randomized to 4 g/d of purified
EPA, DHA, or olive oil (placebo) capsules and continued their usual
diets for 6 weeks. Fifty-six subjects completed the study. Only DHA
reduced 24-hour and daytime (awake) ambulatory BP
(P<0.05). Relative to the placebo group, 24-hour BP
fell 5.8/3.3 (systolic/diastolic) mm Hg and
daytime BP fell 3.5/2.0 mm Hg with DHA. DHA also significantly
reduced 24-hour, daytime, and nighttime (asleep) ambulatory HRs
(P=0.001). Relative to the placebo group, DHA reduced
24-hour HR by 3.5±0.8 bpm, daytime HR by 3.7±1.2 bpm, and nighttime
HR by 2.8±1.2. EPA had no significant effect on ambulatory BP or HR.
Supplementation with EPA increased plasma phospholipid EPA from
1.66±0.07% to 9.83±0.06% (P<0.0001) but did not
change DHA levels. Purified DHA capsules increased plasma phospholipid
DHA levels from 4.00±0.27% to 10.93±0.62%
(P<0.0001) and led to a small, nonsignificant increase
in EPA (1.52±0.12% to 2.26±0.16%). Purified DHA but not EPA reduced
ambulatory BP and HR in mildly hyperlipidemic men. The
results of this study suggest that DHA is the principal 3 fatty acid
in fish and fish oils that is responsible for their BP- and HR-lowering
effects in humans. These results have important implications for human
nutrition and the food industry.
Key Words: eicosapentaenoic acid • docosahexaenoic acid • fatty acids • blood pressure • heart rate
This article has been cited by other articles:
 |
|
 |
|
  B. Valera, E. Dewailly, and P. Poirier Environmental Mercury Exposure and Blood Pressure Among Nunavik Inuit Adults Hypertension, November 1, 2009; 54(5): 981 - 986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Rennison and D. R. Van Wagoner Impact of Dietary Fatty Acids on Cardiac Arrhythmogenesis Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 460 - 469. [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Fetterman Jr. and M. M. Zdanowicz Therapeutic potential of n-3 polyunsaturated fatty acids in disease Am. J. Health Syst. Pharm., July 1, 2009; 66(13): 1169 - 1179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. K. Gabler, J. D. Spencer, D. M. Webel, and M. E. Spurlock In Utero and Postnatal Exposure to Long Chain (n-3) PUFA Enhances Intestinal Glucose Absorption and Energy Stores in Weanling Pigs J. Nutr., November 1, 2007; 137(11): 2351 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Yagil and Y. Yagil Peroxisome Proliferator-Activated Receptor {alpha}: Friend or Foe? Hypertension, November 1, 2007; 50(5): 847 - 850. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Prabodh Shah, A. M. Ichiuji, J. K. Han, M. Traina, A. El-Bialy, S. Kamal Meymandi, and R. Yvonne Wachsner Cardiovascular and Endothelial Effects of Fish Oil Supplementation in Healthy Volunteers Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 213 - 219. [Abstract] [PDF]
|
|
|
|
|
|
H. E. Theobald, A. H. Goodall, N. Sattar, D. C. S. Talbot, P. J. Chowienczyk, and T. A. B. Sanders Low-Dose Docosahexaenoic Acid Lowers Diastolic Blood Pressure in Middle-Aged Men and Women J. Nutr., April 1, 2007; 137(4): 973 - 978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Schwellenbach, K. L. Olson, K. J. McConnell, R. S. Stolcpart, J. D. Nash, J. A. Merenich, and for the Clinical Pharmacy Cardiac Risk Service Stu The Triglyceride-Lowering Effects of a Modest Dose of Docosahexaenoic Acid Alone Versus in Combination with Low Dose Eicosapentaenoic Acid in Patients with Coronary Artery Disease and Elevated Triglycerides J. Am. Coll. Nutr., December 1, 2006; 25(6): 480 - 485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Gudbrandsen, M. Hultstrom, S. Leh, L. Monica Bivol, O. Vagnes, R. K. Berge, and B. M. Iversen Prevention of Hypertension and Organ Damage in 2-Kidney, 1-Clip Rats by Tetradecylthioacetic Acid Hypertension, September 1, 2006; 48(3): 460 - 466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Larnkjaer, J. H. Christensen, K. F. Michaelsen, and L. Lauritzen Maternal Fish Oil Supplementation during Lactation Does Not Affect Blood Pressure, Pulse Wave Velocity, or Heart Rate Variability in 2.5-y-old Children J. Nutr., June 1, 2006; 136(6): 1539 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan Effect of Fish Oil on Heart Rate in Humans: A Meta-Analysis of Randomized Controlled Trials Circulation, September 27, 2005; 112(13): 1945 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Michalsen and G. J. Dobos Heart rate reduction through lifestyle modification Eur. Heart J., September 1, 2005; 26(17): 1806 - 1807. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Geelen, I. A Brouwer, E. G Schouten, A. C Maan, M. B Katan, and P. L Zock Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans Am. J. Clinical Nutrition, February 1, 2005; 81(2): 416 - 420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D Stark and B. J Holub Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy Am. J. Clinical Nutrition, May 1, 2004; 79(5): 765 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G Owen, P. H Whincup, J. A Gilg, and D. G Cook Effect of breast feeding in infancy on blood pressure in later life: systematic review and meta-analysis BMJ, November 22, 2003; 327(7425): 1189 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Dallongeville, J. Yarnell, P. Ducimetiere, D. Arveiler, J. Ferrieres, M. Montaye, G. Luc, A. Evans, A. Bingham, B. Hass, et al. Fish Consumption Is Associated With Lower Heart Rates Circulation, August 19, 2003; 108(7): 820 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J S Forsyth, P Willatts, C Agostoni, J Bissenden, P Casaer, and G Boehm Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: follow up of a randomised controlled trial BMJ, May 3, 2003; 326(7396): 953 - 953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, J. D. Best, and L. J. Beilin Docosahexaenoic Acid But Not Eicosapentaenoic Acid Increases LDL Particle Size in Treated Hypertensive Type 2 Diabetic Patients Diabetes Care, January 1, 2003; 26(1): 253 - 253. [Full Text] [PDF]
|
|
|
|
|
|
Q. N. Diep, F. Amiri, R. M. Touyz, J. S. Cohn, D. Endemann, M. F. Neves, and E. L. Schiffrin PPAR{alpha} Activator Effects on Ang II-Induced Vascular Oxidative Stress and Inflammation Hypertension, December 1, 2002; 40(6): 866 - 871. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J Woodman, T. A Mori, V. Burke, I. B Puddey, G. F Watts, and L. J Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1007 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.P.M Leeson, A Mann, M Kattenhorn, J.E Deanfield, A Lucas, and D.P.R Muller Relationship between circulating n-3 fatty acid concentrations and endothelial function in early adulthood Eur. Heart J., February 1, 2002; 23(3): 216 - 222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Curtis and J. H. O'Keefe Jr Autonomic Tone as a Cardiovascular Risk Factor: The Dangers of Chronic Fight or Flight Mayo Clin. Proc., January 1, 2002; 77(1): 45 - 54. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Y Abeywardena and R. J Head Longchain n-3 polyunsaturated fatty acids and blood vessel function Cardiovasc Res, December 1, 2001; 52(3): 361 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T Holm, A.K Andreassen, P Aukrust, K Andersen, O.R Geiran, J Kjekshus, S Simonsen, and L Gullestad Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients Eur. Heart J., March 1, 2001; 22(5): 428 - 436. [Abstract] [PDF]
|
|
|
|
|
|
J.-M. R. Frenoux, E. D. Prost, J. L. Belleville, and J. L. Prost A Polyunsaturated Fatty Acid Diet Lowers Blood Pressure and Improves Antioxidant Status in Spontaneously Hypertensive Rats J. Nutr., January 1, 2001; 131(1): 39 - 45. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. G. Warner Complementary and Alternative Therapies for Hypertension Complementary Health Practice Review, October 1, 2000; 6(1): 11 - 19. [PDF]
|
|
|
|
|
|
T. A. Mori, G. F. Watts, V. Burke, E. Hilme, I. B. Puddey, and L. J. Beilin Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Vascular Reactivity of the Forearm Microcirculation in Hyperlipidemic, Overweight Men Circulation, September 12, 2000; 102(11): 1264 - 1269. [Abstract] [Full Text] [PDF]
|
|